369 related articles for article (PubMed ID: 15708075)
1. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P
Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
[TBL] [Abstract][Full Text] [Related]
2. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
Brady CM; Apostolidis AN; Harper M; Yiangou Y; Beckett A; Jacques TS; Freeman A; Scaravilli F; Fowler CJ; Anand P
BJU Int; 2004 Apr; 93(6):770-6. PubMed ID: 15049988
[TBL] [Abstract][Full Text] [Related]
3. P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.
Brady CM; Apostolidis A; Yiangou Y; Baecker PA; Ford AP; Freeman A; Jacques TS; Fowler CJ; Anand P
Eur Urol; 2004 Aug; 46(2):247-53. PubMed ID: 15245821
[TBL] [Abstract][Full Text] [Related]
4. Autonomous contractile activity in the isolated rat bladder is modulated by a TRPV1 dependent mechanism.
Gevaert T; Vandepitte J; Ost D; Nilius B; De Ridder D
Neurourol Urodyn; 2007; 26(3):424-32; discussion 451-3. PubMed ID: 17004230
[TBL] [Abstract][Full Text] [Related]
5. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
6. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
Heng YJ; Saunders CI; Kunde DA; Geraghty DP
Regul Pept; 2011 Apr; 167(2-3):250-8. PubMed ID: 21329730
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
Liu HT; Kuo HC
BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
[TBL] [Abstract][Full Text] [Related]
8. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
Roosen A; Datta SN; Chowdhury RA; Patel PM; Kalsi V; Elneil S; Dasgupta P; Kessler TM; Khan S; Panicker J; Fry CH; Brandner S; Fowler CJ; Apostolidis A
Eur Urol; 2009 Jun; 55(6):1440-8. PubMed ID: 19054608
[TBL] [Abstract][Full Text] [Related]
9. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells.
Charrua A; Reguenga C; Cordeiro JM; Correiade-Sá P; Paule C; Nagy I; Cruz F; Avelino A
J Urol; 2009 Dec; 182(6):2944-50. PubMed ID: 19846148
[TBL] [Abstract][Full Text] [Related]
10. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin.
Apostolidis AN; Yiangou Y; Brady CM; Ford AP; Baecker PA; Jacques TS; Freeman A; Fowler CJ; Anand P
BJU Int; 2004 Feb; 93(3):336-40. PubMed ID: 14764132
[TBL] [Abstract][Full Text] [Related]
12. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
Apostolidis A; Jacques TS; Freeman A; Kalsi V; Popat R; Gonzales G; Datta SN; Ghazi-Noori S; Elneil S; Dasgupta P; Fowler CJ
Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564
[TBL] [Abstract][Full Text] [Related]
13. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.
Apostolidis A; Popat R; Yiangou Y; Cockayne D; Ford AP; Davis JB; Dasgupta P; Fowler CJ; Anand P
J Urol; 2005 Sep; 174(3):977-82; discussion 982-3. PubMed ID: 16094018
[TBL] [Abstract][Full Text] [Related]
14. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D
Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
[TBL] [Abstract][Full Text] [Related]
15. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
[TBL] [Abstract][Full Text] [Related]
16. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations.
Mukerji G; Yiangou Y; Grogono J; Underwood J; Agarwal SK; Khullar V; Anand P
J Urol; 2006 Jul; 176(1):367-73. PubMed ID: 16753445
[TBL] [Abstract][Full Text] [Related]
17. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H
J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
[TBL] [Abstract][Full Text] [Related]
18. Intravesical vanilloids and neurogenic incontinence: ten years experience.
Lazzeri M; Spinelli M; Zanollo A; Turini D
Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
[TBL] [Abstract][Full Text] [Related]
19. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract.
Stein RJ; Santos S; Nagatomi J; Hayashi Y; Minnery BS; Xavier M; Patel AS; Nelson JB; Futrell WJ; Yoshimura N; Chancellor MB; De Miguel F
J Urol; 2004 Sep; 172(3):1175-8. PubMed ID: 15311065
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
Apostolidis A; Gonzales GE; Fowler CJ
Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
